Periconceptional folic acid use and the prevalence of neural tube defects in The Netherlands

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 108, Issue 1, 2003, Pages 33-39

  Van Der Pal De Bruin, Karin M ^a   Van Der Heijden, Peter G M ^a   Buitendijk, Simone E ^a   Den Ouden, A Lya ^a  

^a TNO   (Netherlands)

Author keywords

Folic acid use; Prevalence NTD; Trend

Indexed keywords

FOLIC ACID;

ARTICLE; BIRTH; CONTROLLED STUDY; DRUG EFFECT; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS; NEURAL TUBE DEFECT; NEWBORN; PREVALENCE; PRIORITY JOURNAL; REGISTER; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

EID: 0037402419     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(02)00362-7     Document Type: Article

References (30)

1. Ouden A.L. den., Hirasing R.A., Buitendijk S.E., Jong-van den Berg L.T.W. de., Walle H.E.K. de., Cornel M.C. Prevalentie, klinisch beeld en prognose van neuralebuisdefecten in Nederland. Ned. Tijdschr. Geneeskd. 140:1996;2092-2095.
2. Mulinare J., Cordero J.F., Erickson J.D., Berry R.J. Periconcetional use of multivitamins and the occurrence of neural tube defects. JAMA. 260(21):1988;3141-3145.
3. Milunsky A., Jick H., Jick S.S., Bruell C.L., MacLaughlin D.S., Rothman K.J.et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects [see comments]. JAMA. 262(20):1989;2847-2852.
4. Werler M.M., Shapiro S., Mitchell A.A. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA. 269:1993;1257-1261.
5. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the medical research council vitamin study. Lancet 1991;338:131-7.
6. Czeizel A.E., Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation [see comments]. N. Engl. J. Med. 327(26):1992;1832-1835.
7. Berry R.J., Li Z., Erickson J.D., Li S., Moore C.A., Wang H.et al. Prevention of neural-tube defects with folic acid in China. China-US collaborative project for neural tube defect prevention. N. Engl. J. Med. 341(20):1999;1485-1490.
8. Pal-de Bruin K.M. van der, Walle H.E.K. de., Jeeninga W., Rover C.M. de., Cornel M.C., Jong-van den Berg L.T.W., de Schouten J., Brand R., Buitenijk S.E. The Dutch 'folic acid campaign'. Have the goals been achieved? Pead. Perinatal. Epidemiol. 14:2000;111-117.
9. Walle H.E.K. de., de-Jong-van den Berg L.T.W., Cornel M.C. Periconceptional folic acid intake in the northern Netherlands [letter]. Lancet. 353:1999;1187.
10. Seber GAF. The estimation of animal abundance and related parameters. 2nd ed. London: Griffin; 1982.
11. International Working Group for Disease Monitoring and Forecasting. Capture-recapture and multiple record systems estimation. Part II. Application in human diseases. Am J Epidemiol 1995;142:1059-68.
12. International Working Group for Disease Monitoring and Forecasting. Capture-recapture and multiple record systems estimation. Part I. History and theoretical development. Am J Epidemiol 1995;142:1047-58.
13. Little and Rubin. Statistical analysis with missing data. New York: Wiley; 1987.
14. Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman & Hall; 1993.
15. Central Bureau of Statistics. Births, 1985-1989. Mndstat bevolking 1990:20-8.
16. Central Bureau of Statistics. Births, 1990-1994. Mndstat bevolking 1995:22-31.
17. Central Bureau of Statistics. Births, 1994-1998. Mndstat bevolking 1999:35-44.
18. Dorrepaal C.A., den Ouden A.L., Cornel M.C. Development of a Dutch database of congenital anomalies based on the Dutch perinatal databases. [Opzetten van een landelijk bestand van kinderen met congenitale afwijkingen uit de Landelijke Verloskunde Registratie en de Landelijke Neonatologie Registratie]. Ned. Tijdschr. Geneeskd. 142:1998;645-649.
19. Chan A., Robertson E.F., Haan E.A., Keane R.J., Ranieri E., Carney A. Prevalence of neural tube defects in South Australia, 1966-1991: effectiveness and impact of prenatal diagnosis. Br. Med. J. 307:1993;703-706.
20. Roberts H.E., Moore C.A., Cragan J.D., Fernhoff P.M., Khoury M.J. Impact of prenatal diagnosis on the birth prevalence of neural tube defects, Atlanta, 1990-1991. Pediatrics. 96:1995;880-883.
21. Velie E.M., Shaw G.M. Impact of prenatal diagnosis and elective termination on prevalence and risk estimates of neural tube defects in California, 1989-1991. Am. J. Epidemiol. 144:1996;473-479.
22. Alembik Y., Dott B., Roth M.P., Stoll C. Prevalence of neural tube defects in northeastern France, 1979-1994. Impact of prenatal diagnosis. Ann. Genet. 40:1997;69-71.
23. Yen I.H., Khoury M.J., Erickson J.D., James L.M., Waters G.D., Berry R.J. The changing epidemiology of neural tube defects. United States, 1968-1989. Am. J. Dis. Child. 146:1992;857-861.
24. Rankin J., Glinianaia S., Brown R., Renwick M. The changing prevalence of neural tube defects: a population-based study in the north of England, 1984-1996. Northern Congenital Abnormality Survey Steering Group. Paediatr. Perinat. Epidemiol. 14:2000;104-110.
25. Reefhuis J, Samrén EB, Diem M Th van, et al. Tables 1981-1998. EUROCAT registration of congenital anomalies. Northern Netherlands and Southwestern Netherlands. Groningen: University of Groningen; 2000.
26. EUROCAT Working Group. EUROCAT report 7. 15 years of surveillance of congenital anomalies in Europe 1980-1994. Scientific Institute of Public Health, Brussels.
27. Cornel M.C. Public health and prevention of congenital anomalies. Int. J. Risk Safety Med. 11:1998;129-142.
28. Rosano A., Smithells D., Cacciani L., Botting B., Castilla E., Cornel M.et al. Time trends in neural tube defects prevalence in relation to preventive strategies: an international study. J. Epidemiol. Commun. Health. 53:1999;630-635.
29. Honein M.A., Paulozzi L.J., Mathews T.J., Erickson J.D., Wong L.Y. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA. 285(23):2001;2981-2986.
30. Mills J.L., England L. Food fortification to prevent neural tube defects: is it working? JAMA. 285(23):2001;3022-3023.